Skip to main content
Premium Trial:

Request an Annual Quote

Is Genomic Testing Better for Primary-Care Clinicians?

Think Gene's Andrew Yates says he'd use some of the genomic technology available today in his primary-care practice. He calls ancestry, ethnicity, and sex screening "the greatest strength of all genomic testing," and would ideally include it with scheduled vaccinations and complete physicals on new patients.
Yates says the testing could help clinicians get around several ambiguities about their patients like their ethnicity – which the patients may not know themselves – or their familial medical history – which they could be mistaken about. Also, Yates says, "patients lie, especially about culturally taboo topics which they do not feel are immediately relevant to their primary medical complaint." As an aside, he writes, it's funny to read the criticism of the accuracy of genomic data because the critics don't know how inaccurate actual medical data can be. Even when it comes to the patient's sex, Yates says, the 99.9 percent confidence for a genomic sex test is "almost certainly higher that the existing confidence derived from asking the patient."

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.